• Featured Product
  • KD/KO Validated

AlaRS Monoklonaler Antikörper

AlaRS Monoklonal Antikörper für WB, IF/ICC, IF-P, Indirect ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IF/ICC, IF-P, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1C8H3

Kat-Nr. : 67909-1-PBS

Synonyme

AARS, 1C8H3, AARS1, Alanine--tRNA ligase, cytoplasmic, Alanyl-tRNA synthetase



Geprüfte Anwendungen

Produktinformation

67909-1-PBS bindet in WB, IF/ICC, IF-P, Indirect ELISA AlaRS und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen AlaRS fusion protein Ag11151
Vollständiger Name alanyl-tRNA synthetase
Berechnetes Molekulargewicht 968 aa, 107 kDa
Beobachtetes Molekulargewicht107 kDa
GenBank-ZugangsnummerBC011451
Gene symbol AlaRS
Gene ID (NCBI) 16
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

AARS(alanyl-tRNA synthetase) is also named as AlaRS(alanine tRNA ligase 1, cytoplasmic), renal carcinoma antigen NY-REN-42 and belongs to the class-II aminoacyl-tRNA synthetase family. It can interpret the RNA code and attach specific aminoacids to the tRNAs that contain the cognate trinucleotide anticodons. AARS consists of three domains: the N-terminal catalytic domain, the editing domain and the C-terminal C-Ala domain. The editing domain removes incorrectly charged amino acids, while the C-Ala domain, along with tRNA(Ala), serves as a bridge to cooperatively bring together the editing and aminoacylation centers thus stimulating deacylation of misacylated tRNAs(PMID:19661429).